Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clareon PanOptix Pro vs. Clareon PanOptix - Study B

NCT: NCT06401551 · COMPLETED

NCT IDNCT06401551
StatusCOMPLETED
Start Date2024-06-18
Completion2025-04-30
SponsorAlcon Research (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the safety and effectiveness of Clareon™ PanOptix™ Pro Trifocal Intraocular Lens (IOL) compared to Clareon™ PanOptix™ Trifocal IOL.

Frequently Asked Questions

What is Clareon PanOptix Pro vs. Clareon PanOptix - Study B?

Clareon PanOptix Pro vs. Clareon PanOptix - Study B is a clinical trial registered under NCT06401551. Current status: COMPLETED.

What is the status of NCT06401551?

The current status of NCT06401551 (Clareon PanOptix Pro vs. Clareon PanOptix - Study B) is: COMPLETED.

When did Clareon PanOptix Pro vs. Clareon PanOptix - Study B start?

Clareon PanOptix Pro vs. Clareon PanOptix - Study B started on 2024-06-18.

Related Devices

PMA P040020Lens, multifocal intraocularAlcon Research, Ltd. K161794CENTURION Vision System (Active SentryTM)Alcon Research, Ltd. K170520HyperVit Vitrectomy Probe, 23 GA, HyperVit Vitrectomy Probe, 25+, HyperVit Vitrectomy Probe, 27+Alcon Research, Ltd. K191650LEGION SystemAlcon Research, LLC PMA P150037Intraocular pressure lowering implantAlcon Research, Ltd.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑